Lab suppliers working to sell lab equipment and increase life science sales leads at Utah life science marketing events may be interested in the latest grant news at the University of Utah. Researchers studying metabolic disorders such as obesity, diabetes and metabolic syndrome have received a $2.5 million award from the NIH. According to the NIH RePORTER, the study, titled “Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes,” will be led by University of Utah internal medicine researcher Andrew S. Weyrich, Ph.D. The project’s abstract states:
“The broad objective of the University of Utah Molecular Medicine Translation Research Center in Thrombosis (U2M2-TRCT) is to dissect novel clinical and molecular determinants of thrombotic risk in patients with metabolic disorders (obesity, diabetes, and the metabolic syndrome). The U2M2-TRCT unites a group of basic and clinical investigators with breadth and expertise in thrombosis and metabolic dysregulation. Our studies will test the thematic hypothesis that metabolic changes in the systemic milieu reprogram platelet precursors and platelets themselves, resulting in altered thrombotic activities of these critical cells. To examine this central theme, we propose four research projects and four cores and studies by a cadre of established and emerging investigators with proven track records of productive interactions.”
The University of Utah researchers’ four projects include:
- The Molecular Regulation of Platelet Reprogramming by the Metabolic Milieu
- Metabolic Regulation of Platelet Reprogramming
- The Role of the Metabolic Milieu in Regulating Platelet Reprogramming in Humans
- Platelet Reprogramming in Human Obesity and Diabetes
University of Utah
Image courtesy of Wikimedia Commons
In addition to receiving this $2.5 million grant, the University of Utah receives a great deal of funding from outside sources, such as private donors, the NSF and the NIH that make the market an attractive option for lab suppliers working to sell lab equipment and increase life science sales leads. The University of Utah also has an impressive budget: In 2010, the NSF ranked the University of Utah 50th in the country for total R&D expenditures in the life sciences, the total amount being $237.7 million. In 2011, the NIH ranked the school 43rd for direct plus indirect costs in the life sciences, excluding R&D contracts and ARRA awards. The total expenditures in 2011 were $135.8 million.
According to the University of Utah website, “the university's external research funding in 2011 generated $597 million in gross state product, 8,538 Utah jobs with total wages of $311 million, and $31.9 million in state and local tax revenue.”
If you are a lab supplier working to sell lab equipment and increase life science sales leads, Biotechnology Calendar, Inc. invites you to attend our annual Salt Lake City BioResearch Product Faire™ Event on August 15, 2013. Last year, the Salt Lake City BioResearch Product Faire™ Event attracted 200 attendees. Of those attending, 56 were purchasing agents, professors and post docs, and 20 were lab managers. The attendees came from 15 research buildings and 28 departments around campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that has been organizing life science marketing events for 20 years. If you would like to sell lab equipment and increase life science sales leads at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more funding statistics on the University of Utah or more information about the Salt Lake City BioResearch Product Faire™ Event, click on the button below.
